Visualant ChromaID Technology Identifies Gluten

Visualant, Inc. (OTCQB: VSUL) – a provider of chromatic-based identification, authentication and diagnostic solutions, with its ChromaID™ technology, announced today that it has successfully identified gluten-free flour in blind testing of multiple flour samples.

Increasingly consumers are concerned about the presence of gluten and other potential allergens in food products. Gluten is the general name for a protein found in wheat, rye and barley. While a small percentage of the population have celiac disease, a serious auto-immune disease, and cannot eat gluten, many people report a sensitivity to gluten.

“The ability to identify common allergens, including gluten, represents a potentially significant application of our patented ChromaID technology. We continue to work in our lab and with potential customers to develop specific applications for our technology. Our laboratory results are further evidence of the capacity of our ChromaID technology to identify and authenticate substances and materials,” said Visualant CEO, President and Founder, Ron Erickson. “We continue to work to explore the broad range of applications for ChromaID.”

About Visualant, Inc.

Visualant™ is a public company whose shares trade under the stock symbol “VSUL.” The Visualant Spectral Pattern Matching™ (SPM) technology directs structured light onto a substance or material, through a liquid or gas, or off a surface, to capture a unique ChromaID™. A ChromaID can be used to identify, detect, or diagnosis markers invisible to the human eye. ChromaID scanner modules can be integrated into a variety of mobile or fixed-mount form factors. The patented, award-winning technology is disruptive, making it possible to effectively conduct analyses in the field that could only previously be performed by large and expensive lab-based tests. For more information on Visualant, visit the company’s website at www.visualant.net.

Safe Harbor Statement

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements (within the meaning of Section 27a of the Securities Act of 1933 and Section 21e of the Securities Exchange Act of 1934) regarding us and our business, financial condition, results of operations and prospects. Forward-looking statements in this press release reflect the good faith judgment of our management and are based on facts and factors currently known to us. Forward-looking statements are subject to risks and uncertainties, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements as a result of either the matters set forth or incorporated in this press release generally or certain economic and business factors, some of which may be unknown to and/or beyond the control of Visualant, Inc. Specifically, we are exposed to various risks related to our need for additional financing to support our technology development, the sale of a significant number of our shares of common stock could depress the price of our common stock, acquiring or investing in new businesses and ongoing operations, we may incur losses in the future and the market price of our common stock may be volatile. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We do not undertake, and we expressly disclaim, any obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of the press release.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160929005295/en/